{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:42Z","timestamp":1786120302330,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/cad.0b013e32834a099c","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T18:32:56Z","timestamp":1317753176000},"page":"22-31","source":"Crossref","is-referenced-by-count":18,"title":["Methyl-\u03b2-cyclodextrin induces programmed cell death in chronic myeloid leukemia cells and, combined with imatinib, produces a synergistic downregulation of ERK\/SPK1 signaling"],"prefix":"10.1097","volume":"23","author":[{"given":"Jun","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-Tse","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210203","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1182\/blood.V98.13.3860","article-title":"The antitumor ether lipid ET-18-OCH (3) induces apoptosis through translocation and capping of FasCD95 into membrane rafts in human leukemic cells.","volume":"98","author":"Gajate","year":"2001","journal-title":"Blood"},{"key":"R2-3-20210203","doi-asserted-by":"crossref","first-page":"e5044","DOI":"10.1371\/journal.pone.0005044","article-title":"Involvement of raft aggregates enriched in FasCD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells.","volume":"4","author":"Gajate","year":"2009","journal-title":"PLoS One"},{"key":"R3-3-20210203","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1038\/onc.2009.183","article-title":"Involvement of mitochondria and recruitment of FasCD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions.","volume":"28","author":"Reis-Sobreiro","year":"2009","journal-title":"Oncogene"},{"key":"R4-3-20210203","doi-asserted-by":"crossref","first-page":"19876","DOI":"10.1074\/jbc.M200324200","article-title":"Loss of plasma membrane phospholipid asymmetry requires raft integrity. Role of transient receptor potential channels and ERK pathway.","volume":"277","author":"Kunzelmann-Marche","year":"2002","journal-title":"J Biol Chem"},{"key":"R5-3-20210203","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/path.2531","article-title":"Cholesterol depletion induces anoikis-like apoptosis via FAK down-regulation and caveolae internalization.","volume":"218","author":"Park","year":"2009","journal-title":"J Pathol"},{"key":"R6-3-20210203","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.4049\/jimmunol.178.8.5253","article-title":"Free cholesterol alters lipid raft structure and function regulating neutrophil Ca2 entry and respiratory burst: correlations with calcium channel raft trafficking.","volume":"178","author":"Kannan","year":"2007","journal-title":"J Immunol"},{"key":"R7-3-20210203","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/carcin\/bgn146","article-title":"Targeting lipid rafts inhibits protein kinase B by disrupting calcium homeostasis and attenuates malignant properties of melanoma cells.","volume":"29","author":"Fedida-Metula","year":"2008","journal-title":"Carcinogenesis"},{"key":"R8-3-20210203","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1600-0625.2006.00481.x","article-title":"Cyclodextrin-induced apoptosis in human keratinocytes is caspase-8 dependent and accompanied by mitochondrial cytochrome c release.","volume":"15","author":"Schonfelder","year":"2006","journal-title":"Exp Dermatol"},{"key":"R9-3-20210203","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1111\/j.1742-4658.2008.06630.x","article-title":"Neurotrophic signalling pathway triggered by prosaposin in PC12 cells occurs through lipid rafts.","volume":"275","author":"Sorice","year":"2008","journal-title":"FEBS J"},{"key":"R10-3-20210203","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.3460176","article-title":"The chronic myelogenous leukemia-specific P210 protein is the product of the bcrabl hybrid gene.","volume":"233","author":"Ben-Neriah","year":"1986","journal-title":"Science"},{"key":"R11-3-20210203","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/shem.2003.50034","article-title":"Molecular mechanisms of transformation by the BCR-ABL oncogene.","volume":"40","author":"Sattler","year":"2003","journal-title":"Semin Hematol"},{"key":"R12-3-20210203","doi-asserted-by":"crossref","first-page":"7904","DOI":"10.1038\/sj.onc.1210587","article-title":"Sphingosine kinase-1 mediates BCRABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells.","volume":"26","author":"Li","year":"2007","journal-title":"Oncogene"},{"key":"R13-3-20210203","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification.","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"R14-3-20210203","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.","volume":"346","author":"Kantarjian","year":"2002","journal-title":"N Engl J Med"},{"key":"R15-3-20210203","doi-asserted-by":"crossref","first-page":"e6257","DOI":"10.1371\/journal.pone.0006257","article-title":"Synergy between proteasome inhibitors and imatinib mesylate in chronic myeloid leukemia.","volume":"4","author":"Hu","year":"2009","journal-title":"PLOS One"},{"key":"R16-3-20210203","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood-2006-10-050260","article-title":"Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance.","volume":"110","author":"Carew","year":"2007","journal-title":"Blood"},{"key":"R17-3-20210203","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng1343","article-title":"Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.","volume":"36","author":"Hu","year":"2004","journal-title":"Nature Genetics"},{"key":"R18-3-20210203","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1096\/fj.07-101394","article-title":"Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol.","volume":"22","author":"Puissant","year":"2008","journal-title":"FASEB J"},{"key":"R19-3-20210203","doi-asserted-by":"crossref","first-page":"e8532","DOI":"10.1371\/journal.pone.0008532","article-title":"Avicin D, a plant triterpenoid, induces cell apoptosis by recruitment of Fas and downstream signaling molecules into lipid rafts.","volume":"4","author":"Xu","year":"2009","journal-title":"PLoS One"},{"key":"R20-3-20210203","doi-asserted-by":"crossref","first-page":"14465","DOI":"10.1074\/jbc.M600457200","article-title":"Cytoplasmic function of mutant promyelocytic leukemia (PML) and PML-retinoic acid receptor-alpha.","volume":"281","author":"Bellodi","year":"2006","journal-title":"J Biol Chem"},{"key":"R21-3-20210203","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/bjs.5890","article-title":"Sphingosine kinase 1 gene transfer reduces postoperative peritoneal adhesion in an experimental model.","volume":"95","author":"Guo","year":"2008","journal-title":"Br J Surg"},{"key":"R22-3-20210203","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1600-0625.2006.00481.x","article-title":"Cyclodextrin-induced apoptosis in human keratinocytes is caspase-8 dependent and accompanied by mitochondrial cytochrome c release.","volume":"15","author":"Schonfelder","year":"2006","journal-title":"Exp Dermatol"},{"key":"R23-3-20210203","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","article-title":"LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.","volume":"19","author":"Kabeya","year":"2000","journal-title":"EMBO J"},{"key":"R24-3-20210203","doi-asserted-by":"crossref","first-page":"13123","DOI":"10.1074\/jbc.M700492200","article-title":"Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin1 is a novel BH3-only protein.","volume":"282","author":"Oberstein","year":"2007","journal-title":"J Biol Chem"},{"key":"R25-3-20210203","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4161\/auto.6787","article-title":"Beclin 1 bridges autophagy, apoptosis and differentiation.","volume":"4","author":"Wang","year":"2008","journal-title":"Autophagy"},{"key":"R26-3-20210203","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/381800a0","article-title":"Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate.","volume":"381","author":"Cuvillier","year":"1996","journal-title":"Nature"},{"key":"R27-3-20210203","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0960-9822(00)00834-4","article-title":"An oncogenic role of sphingosine kinase.","volume":"10","author":"Xia","year":"2000","journal-title":"Curr Biol"},{"key":"R28-3-20210203","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3109\/07357901003631056","article-title":"Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells.","volume":"28","author":"Baran","year":"2010","journal-title":"Cancer Invest"},{"key":"R29-3-20210203","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbrc.2006.10.042","article-title":"Cholesterol depletion induces autophagy.","volume":"351","author":"Cheng","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"R30-3-20210203","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1038\/sj.onc.1206942","article-title":"Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias.","volume":"22","author":"Shah","year":"2003","journal-title":"Oncogene"},{"key":"R31-3-20210203","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","article-title":"Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia.","volume":"2","author":"Shah","year":"2002","journal-title":"Cancer Cell"},{"key":"R32-3-20210203","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/sj.leu.2404151","article-title":"The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib.","volume":"20","author":"Miething","year":"2006","journal-title":"Leukemia"},{"key":"R33-3-20210203","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1073\/pnas.0408283102","article-title":"A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance.","volume":"102","author":"Gumireddy","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"R34-3-20210203","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2005-11-4639","article-title":"Combined effects of novel tyrosine kinase inhibitor AMN107 and histone deacetylase inhibitor LBH589 against Bcr-Abl-expressing human leukemia cells.","volume":"108","author":"Fiskus","year":"2006","journal-title":"Blood"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e32834a099c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:24:22Z","timestamp":1786047862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-201201000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e32834a099c","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}